GPC5 and lung cancer in multiple sclerosis

The Lancet Oncology

Volumn 11, Issue 8, 2010, Pages 714-

  Handel, Adam E ^a,b   Ramagopalan, Sreeram V ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYPICAN; GLYPICAN 5; UNCLASSIFIED DRUG;

CANCER RISK; CANCER SUSCEPTIBILITY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOME ANALYSIS; GENOTYPE; HUMAN; LETTER; LUNG CANCER; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY TRACT CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC PREDISPOSITION TO DISEASE; GLYPICANS; HUMANS; LUNG NEOPLASMS; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77955249438     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70177-7     Document Type: Letter

References (7)

1. Li Y, Sheu CC, Ye Y, et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol 2010, 11:321-330.
2. Baranzini SE, Wang J, Gibson RA, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009, 18:767-778.
3. Handel AE, Ramagopalan SV Multiple sclerosis and risk of cancer: a meta-analysis. J Neurol Neurosurg Psychiatry 2010, in press.
4. Nielsen NM, Rostgaard K, Rasmussen S, et al. Cancer risk among patients with multiple sclerosis: a population-based register study. Int J Cancer 2006, 118:979-984.
5. Hernan MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H Cigarette smoking and the progression of multiple sclerosis. Brain 2005, 128:1461-1465.
6. Frazer KA, Ballinger DG, Cox DR, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
7. Veugelers M, Vermeesch J, Reekmans G, Steinfeld R, Marynen P, David G Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family. Genomics 1997, 40:24-30.